In addition, we analyzed the characteristics of the tumor immune microenvironment, including tumor-infiltrating cell composition, TMB, TP53 mutation rates, and the mRNA expression levels of PD-1/PD-L1/CLTA4. The gene discussed is PDCD1; the disease is neoplasm.